TXG) develops single-cell and spatial genomics solutions, enabling researchers to analyze biological systems at high resolution. Free cash flow isn't a prominently featured metric in company ...
10x Genomics has set its FY 2025 guidance at EPS.Investors interested in registering for the company’s conference call can do so using this link. 10x Genomics (NASDAQ:TXG – Get Free Report ...
Serge Saxonov, the Chief Executive Officer of $TXG, sold 7,942 shares of the company on 02-28-2025 for an estimated $84,393. We received data on the trade from a ...
Several other equities analysts have also recently commented on TXG. UBS Group cut their price target on 10x Genomics from $20.00 to $14.00 and set a “neutral” rating for the company in a ...
ALAN MATEO, a director at $TXG, bought 40,000 shares of the company on 02-21-2025 for an estimated $445,572. This trade was reported by Quiver Quantitative using data ...
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...
Sinn Féin MEP Lynn Boylan has called for EU action after she was refused entry to Israel and put on a return flight to Belgium. Ms Boylan was part of a European Parliament delegation alongside ...
Hosted on MSN7d
2 Reasons to Sell TXG and 1 Stock to Buy InsteadFounded in 2012, 10x Genomics (NASDAQ:TXG) develops single-cell and spatial genomics solutions, enabling researchers to ...
Torex Gold Resources Inc. operates as an intermediate gold producer. The company engages in the exploration, development, and operation of principal asset comprising 100% owned the Morelos Gold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results